Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Richard Milne. (2016) In search of lost time: age and the promise of induced pluripotent stem cell models of the brain. New Genetics and Society 35:4, pages 393-408.
Read now
Read now
Wei-Dong Yao & Chun-Fang Wu. (2014) Exploring the Genetic Underpinnings of Brain and Behavioral Disorders. Journal of Neurogenetics 28:1-2, pages 1-4.
Read now
Read now
Articles from other publishers (46)
Samoil Sekulovski & Simon Trowitzsch. (2022) What connects splicing of transfer RNA precursor molecules with pontocerebellar hypoplasia?. BioEssays 45:2.
Crossref
Crossref
Amy McCaughey-Chapman, Marta Tarczyluk-Wells, Catharina Combrinck, Nicole Edwards, Kathryn Jones & Bronwen Connor. (2023) Reprogramming of adult human dermal fibroblasts to induced dorsal forebrain precursor cells maintains aging signatures. Frontiers in Cellular Neuroscience 17.
Crossref
Crossref
Valeria Lucchino, Luana Scaramuzzino, Stefania Scalise, Michela Lo Conte, Clara Zannino, Giorgia Lucia Benedetto, Umberto Aguglia, Edoardo Ferlazzo, Giovanni Cuda & Elvira Immacolata Parrotta. (2022) Insights into the Genetic Profile of Two Siblings Affected by Unverricht-Lundborg Disease Using Patient-Derived hiPSCs. Cells 11:21, pages 3491.
Crossref
Crossref
Alessandra Alciati, Angelo Reggiani, Daniela Caldirola & Giampaolo Perna. (2022) Human-Induced Pluripotent Stem Cell Technology: Toward the Future of Personalized Psychiatry. Journal of Personalized Medicine 12:8, pages 1340.
Crossref
Crossref
Lisa Strother, Gareth B. Miles, Alison R. Holiday, Ying Cheng & Gayle H. Doherty. (2021) Long-term culture of SH-SY5Y neuroblastoma cells in the absence of neurotrophins: A novel model of neuronal ageing. Journal of Neuroscience Methods 362, pages 109301.
Crossref
Crossref
Eva Tomaskovic-Crook, Kyle Guerrieri-Cortesi & Jeremy Micah Crook. (2021) Induced pluripotent stem cells for 2D and 3D modelling the biological basis of schizophrenia and screening possible therapeutics. Brain Research Bulletin 175, pages 48-62.
Crossref
Crossref
Anuradha Yadav, Brashket Seth & Rajnish Kumar Chaturvedi. (2020) Brain Organoids: Tiny Mirrors of Human Neurodevelopment and Neurological Disorders. The Neuroscientist 27:4, pages 388-426.
Crossref
Crossref
Wei Niu & Jack M. Parent. (2019) Modeling genetic epilepsies in a dish. Developmental Dynamics 249:1, pages 56-75.
Crossref
Crossref
Shang Song, Danielle Amores, Cheng Chen, Kelly McConnell, Byeongtaek Oh, Ada Poon & Paul M. George. (2019) Controlling properties of human neural progenitor cells using 2D and 3D conductive polymer scaffolds. Scientific Reports 9:1.
Crossref
Crossref
Melissa H. Little, Santhosh V. Kumar & Thomas Forbes. (2019) Recapitulating kidney development: Progress and challenges. Seminars in Cell & Developmental Biology 91, pages 153-168.
Crossref
Crossref
Scott Bell, Nuwan Hettige, Heika Silveira, Huashan Peng, Hanrong Wu, Malvin Jefri, Lilit Antonyan, Ying Zhang, Xin Zhang & Carl Ernst. (2019) Differentiation of Human Induced Pluripotent Stem Cells (iPSCs) into an Effective Model of Forebrain Neural Progenitor Cells and Mature Neurons. BIO-PROTOCOL 9:5.
Crossref
Crossref
Evelyn J. Sauter, Lisa K. Kutsche, Simon D. Klapper & Volker Busskamp. 2019. Fragile-X Syndrome. Fragile-X Syndrome
101
121
.
Eduarda G Z Centeno, Helena Cimarosti & Angela Bithell. (2018) 2D versus 3D human induced pluripotent stem cell-derived cultures for neurodegenerative disease modelling. Molecular Neurodegeneration 13:1.
Crossref
Crossref
Maryam Hatami, Sabine Conrad, Pooyan Naghsh, Gonzalo Alvarez-Bolado & Thomas Skutella. (2018) Cell-Biological Requirements for the Generation of Dentate Gyrus Granule Neurons. Frontiers in Cellular Neuroscience 12.
Crossref
Crossref
Neus Bayó-Puxan, Ana Paula Terrasso, Sophie Creyssels, Daniel Simão, Christina Begon-Pescia, Marina Lavigne, Sara Salinas, Florence Bernex, Assumpció Bosch, Vasiliki Kalatzis, Thierry Levade, Ana Maria Cuervo, Philippe Lory, Antonella Consiglio, Catarina Brito & Eric J. Kremer. (2018) Lysosomal and network alterations in human mucopolysaccharidosis type VII iPSC-derived neurons. Scientific Reports 8:1.
Crossref
Crossref
Lauren M. Watson, Maggie M. K. Wong, Jane Vowles, Sally A. Cowley & Esther B. E. Becker. (2018) A Simplified Method for Generating Purkinje Cells from Human-Induced Pluripotent Stem Cells. The Cerebellum 17:4, pages 419-427.
Crossref
Crossref
Priya Srikanth, Valentina N. Lagomarsino, Christina R. Muratore, Steven C. Ryu, Amy He, Walter M. Taylor, Constance Zhou, Marlise Arellano & Tracy L. Young-Pearse. (2018) Shared effects of DISC1 disruption and elevated WNT signaling in human cerebral organoids. Translational Psychiatry 8:1.
Crossref
Crossref
Yunyao Xie, Ryan J. Schutte, Nathan N. Ng, Kevin C. Ess, Philip H. Schwartz & Diane K. O'Dowd. (2018) Reproducible and efficient generation of functionally active neurons from human hiPSCs for preclinical disease modeling. Stem Cell Research 26, pages 84-94.
Crossref
Crossref
Ryan J. Schutte, Yunyao Xie, Nathan N. Ng, Priscilla Figueroa, An T. Pham & Diane K. O’Dowd. (2018) Astrocyte-enriched feeder layers from cryopreserved cells support differentiation of spontaneously active networks of human iPSC-derived neurons. Journal of Neuroscience Methods 294, pages 91-101.
Crossref
Crossref
Christopher MacKerron, Graham Robertson, Michele Zagnoni & Trevor J. Bushell. (2017) A Microfluidic Platform for the Characterisation of CNS Active Compounds. Scientific Reports 7:1.
Crossref
Crossref
Simona Baronchelli, Alberto La Spada, Aikaterini Ntai, Andrea Barbieri, Paola Conforti, Gloria Saccani Jotti, Serena Redaelli, Angela Bentivegna, Pasquale De Blasio & Ida Biunno. (2017) Epigenetic and transcriptional modulation of WDR5 , a chromatin remodeling protein, in Huntington's disease human induced pluripotent stem cell (hiPSC) model. Molecular and Cellular Neuroscience 82, pages 46-57.
Crossref
Crossref
Anke Hoffmann, Vincenza Sportelli, Michael Ziller & Dietmar Spengler. (2017) Driver or Passenger: Epigenomes in Alzheimer’s Disease. Epigenomes 1:1, pages 5.
Crossref
Crossref
Daniela Cornacchia & Lorenz Studer. (2017) Back and forth in time: Directing age in iPSC-derived lineages. Brain Research 1656, pages 14-26.
Crossref
Crossref
Sheryl Ding, Peter Kingshott, Helmut Thissen, Martin Pera & Peng-Yuan Wang. (2017) Modulation of human mesenchymal and pluripotent stem cell behavior using biophysical and biochemical cues: A review. Biotechnology and Bioengineering 114:2, pages 260-280.
Crossref
Crossref
Ulrich Sauerzopf, Roberto Sacco, Gaia Novarino, Marco Niello, Ana Weidenauer, Nicole Praschak-Rieder, Harald Sitte & Matthäus Willeit. (2017) Are reprogrammed cells a useful tool for studying dopamine dysfunction in psychotic disorders? A review of the current evidence. European Journal of Neuroscience 45:1, pages 45-57.
Crossref
Crossref
Shaohua Wu, Ranjie Xu, Bin Duan & Peng Jiang. (2017) Three-dimensional hyaluronic acid hydrogel-based models for in vitro human iPSC-derived NPC culture and differentiation. Journal of Materials Chemistry B 5:21, pages 3870-3878.
Crossref
Crossref
Louis T. Dang & Jack M. Parent. 2017. Models of Seizures and Epilepsy. Models of Seizures and Epilepsy
247
260
.
Mirjana Pavlović & Ksenija RadotićMirjana Pavlović & Ksenija Radotić. 2017. Animal and Plant Stem Cells. Animal and Plant Stem Cells
71
91
.
Mary G. Dandulakis, Kesavan Meganathan, Kristen L. Kroll, Azad Bonni & John N. Constantino. (2016) Complexities of X chromosome inactivation status in female human induced pluripotent stem cells—a brief review and scientific update for autism research. Journal of Neurodevelopmental Disorders 8:1.
Crossref
Crossref
L. Smirnova, G. Harris, J. Delp, M. Valadares, D. Pamies, H. T. Hogberg, T. Waldmann, M. Leist & T. Hartung. (2015) A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis. Archives of Toxicology 90:11, pages 2725-2743.
Crossref
Crossref
Elsa Vera, Nazario Bosco & Lorenz Studer. (2016) Generating Late-Onset Human iPSC-Based Disease Models by Inducing Neuronal Age-Related Phenotypes through Telomerase Manipulation. Cell Reports 17:4, pages 1184-1192.
Crossref
Crossref
Serena Barral & Manju A. Kurian. (2016) Utility of Induced Pluripotent Stem Cells for the Study and Treatment of Genetic Diseases: Focus on Childhood Neurological Disorders. Frontiers in Molecular Neuroscience 9.
Crossref
Crossref
Hossein Eyni. (2016) Treatment of Neurodegenerative Diseases with Using of Stem Cells/Scaffolds. MOJ Anatomy & Physiology 2:6.
Crossref
Crossref
Adelaide Tousley & Kimberly B. Kegel-Gleason. (2016) Induced Pluripotent Stem Cells in Huntington’s Disease Research: Progress and Opportunity. Journal of Huntington's Disease 5:2, pages 99-131.
Crossref
Crossref
Nicholas J. Brandon. (2016) Uncovering the function of Disrupted in Schizophrenia 1 through interactions with the cAMP phosphodiesterase PDE4: Contributions of the Houslay lab to molecular psychiatry. Cellular Signalling 28:7, pages 749-752.
Crossref
Crossref
Lihi Ben‐Reuven & Orly Reiner. (2016) Modeling the autistic cell: iPSCs recapitulate developmental principles of syndromic and nonsyndromic ASD. Development, Growth & Differentiation 58:5, pages 481-491.
Crossref
Crossref
Boon Chin HengLee Wei LimWutian WuChengfei Zhang. (2016)
An Overview of Protocols for the Neural Induction of Dental and Oral Stem Cells
In Vitro
. Tissue Engineering Part B: Reviews 22:3, pages 220-250.
Crossref
Crossref
A. Borsini & P. A. Zunszain. 2016. Stem Cells in Neuroendocrinology. Stem Cells in Neuroendocrinology
123
133
.
Andrew M. Tidball & Jack M. Parent. (2016) Concise Review: Exciting Cells: Modeling Genetic Epilepsies with Patient-Derived Induced Pluripotent Stem Cells. Stem Cells 34:1, pages 27-33.
Crossref
Crossref
Chae-Seok Lim, Jung-eun Yang, You-Kyung Lee, Kyungmin Lee, Jin-A Lee & Bong-Kiun Kaang. (2015) Understanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patients. Molecular Brain 8:1.
Crossref
Crossref
Xixi Du & Jack M. Parent. (2015) Using Patient-Derived Induced Pluripotent Stem Cells to Model and Treat Epilepsies. Current Neurology and Neuroscience Reports 15:10.
Crossref
Crossref
Elsa Vera & Lorenz Studer. (2015) When rejuvenation is a problem: challenges of modeling late-onset neurodegenerative disease. Development 142:18, pages 3085-3089.
Crossref
Crossref
Lauren M. Watson, Maggie M. K. Wong & Esther B. E. Becker. (2015) Induced pluripotent stem cell technology for modelling and therapy of cerebellar ataxia. Open Biology 5:7, pages 150056.
Crossref
Crossref
Lorenz Studer, Elsa Vera & Daniela Cornacchia. (2015) Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency. Cell Stem Cell 16:6, pages 591-600.
Crossref
Crossref
Jack M Parent & Stewart A Anderson. (2015) Reprogramming patient-derived cells to study the epilepsies. Nature Neuroscience 18:3, pages 360-366.
Crossref
Crossref
Christina R. Muratore, Priya Srikanth, Dana G. Callahan & Tracy L. Young-Pearse. (2014) Comparison and Optimization of hiPSC Forebrain Cortical Differentiation Protocols. PLoS ONE 9:8, pages e105807.
Crossref
Crossref